- Home
- UGRO vs NRXS Comparison
UGRO vs NRXS Comparison
Compare UGRO & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- NRXS
- Stock Information
- Founded
- UGRO 2014
- NRXS 2011
- Country
- UGRO United States
- NRXS United States
- Employees
- UGRO N/A
- NRXS N/A
- Industry
- UGRO Industrial Specialties
- NRXS
- Sector
- UGRO Consumer Discretionary
- NRXS
- Exchange
- UGRO Nasdaq
- NRXS Nasdaq
- Market Cap
- UGRO 18.0M
- NRXS 20.3M
- IPO Year
- UGRO N/A
- NRXS 2023
- Fundamental
- Price
- UGRO $1.43
- NRXS $3.15
- Analyst Decision
- UGRO Strong Buy
- NRXS
- Analyst Count
- UGRO 2
- NRXS 0
- Target Price
- UGRO $5.63
- NRXS N/A
- AVG Volume (30 Days)
- UGRO 41.9K
- NRXS 23.3K
- Earning Date
- UGRO 11-22-2024
- NRXS 11-12-2024
- Dividend Yield
- UGRO N/A
- NRXS N/A
- EPS Growth
- UGRO N/A
- NRXS N/A
- EPS
- UGRO N/A
- NRXS N/A
- Revenue
- UGRO $70,320,066.00
- NRXS $2,456,219.00
- Revenue This Year
- UGRO $14.76
- NRXS $383.16
- Revenue Next Year
- UGRO $21.29
- NRXS N/A
- P/E Ratio
- UGRO N/A
- NRXS N/A
- Revenue Growth
- UGRO 12.08
- NRXS N/A
- 52 Week Low
- UGRO $1.02
- NRXS $2.00
- 52 Week High
- UGRO $2.84
- NRXS $3.89
- Technical
- Relative Strength Index (RSI)
- UGRO 43.12
- NRXS 59.42
- Support Level
- UGRO $1.42
- NRXS $2.25
- Resistance Level
- UGRO $1.69
- NRXS $3.78
- Average True Range (ATR)
- UGRO 0.15
- NRXS 0.42
- MACD
- UGRO -0.04
- NRXS 0.07
- Stochastic Oscillator
- UGRO 3.92
- NRXS 63.58
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).